Quorit Logo
Explore Solutions

Guided by Science. Clinical Intellect.

Home › Quorit Solutions › Biological Matrices › QuoroSkin® / QuoroSkin-D®
QuoroSkin Bioactive Extracellular Matrix Packaging
BIOACTIVE TISSUE SCAFFOLD
COMPOSITION Native Structural Matrix
MMP TARGET Sacrificial Substrate
RESORPTION 100% Bioabsorbable
BIOLOGICAL MATRIX & DERMAL SUBSTITUTE

QuoroSkin® & QuoroSkin-D®

Native Structural Matrices for Matrix Metalloproteinase Modulation and Dermal Regeneration.

QuoroSkin® and QuoroSkin-D® provide a 3D extracellular structural matrix engineered from high-purity structural biomaterials. Designed specifically for recalcitrant chronic wounds trapped in the inflammatory stage, it acts as a sacrificial substrate for excess destructive matrix metalloproteinases (MMPs), protecting native growth factors and directing cellular migration across the wound bed.

check_circle Triple-Helix Structural Integrity: Maintains native structural signals that guide microvascular capillary sprouting.
check_circle QuoroSkin-D® Fenestrated Architecture: Includes micro-perforations allowing continuous exudate egress to secondary dressings.
check_circle No Removal Required: Completely bioassimilated by host tissue, eliminating painful dressing changes.
description Product Monograph (PDF)
BIOLOGICAL RATIONALE

Overcoming the Chronic Inflammatory Plateau

Chronic non-healing wounds exhibit elevated proteolytic enzymes (MMP-2, MMP-8, MMP-9) that degrade newly synthesized extracellular matrix before capillaries can form.

1

MMP Neutralization

QuoroSkin® presents a dense network of cleavage sites that competitively bind and absorb elevated MMPs, neutralizing destructive proteases away from native tissues.

2

Growth Factor Preservation

By deactivating excessive proteases, endogenous platelet-derived (PDGF) and vascular endothelial (VEGF) growth factors are shielded, allowing cellular proliferation.

3

Epithelial Edge Ingrowth

Provides the physical physical bridge required for advancing keratinocytes and fibroblasts to migrate from wound margins toward the center for complete re-epithelialization.

TARGET INDICATIONS

Clinical Utilization Scope

  • check Diabetic foot ulcers stalled in the inflammatory phase (>4 weeks)
  • check Venous leg ulcers unresponsive to compression monotherapy
  • check Dehisced surgical incisions and full-thickness cavity defects
  • check Second-degree thermal burns and clean skin graft donor sites
  • check Non-healing arterial and mixed-etiology lower extremity ulcers
ORDERING CODES

Product Sizes & Packaging

Product Code Dimensions Box Quantity
QuoroSkin® QS-0505 5 cm × 5 cm 5 Sterile Pouches
QuoroSkin® QS-1010 10 cm × 10 cm 5 Sterile Pouches
QuoroSkin-D® Fenestrated QSD-0505 5 cm × 5 cm 5 Sterile Pouches
QuoroSkin-D® Fenestrated QSD-1010 10 cm × 10 cm 5 Sterile Pouches
verified

QuoroSkin-D® features micro-fenestrations engineered to allow copious wound fluid passage directly into secondary absorbent foam dressings without pooling or detachment.